Biotechnology and Pharmaceuticals 

Biotechnology
The business climate for biotechnology companies has undergone fundamental change—from mergers and acquisitions and strategic partnerships to exploration of new foreign markets and increasing regulatory scrutiny. To ensure success and growth in the marketplace, companies must develop strategies to become and remain profitable.

Our professionals understand the areas critical to the growth and development of biotechnology companies. From identifying research and development financing opportunities, to staying abreast of the evolving audit and accounting environment and providing value-added transaction services, we can help companies achieve their business objectives.

We have knowledgeable insight forged by years of hands-on experience, and the dedication to apply it to our clients’ prospective success during the dramatic industry growth and development ahead.

Robert Jolicoeur

Robert Jolicoeur

Partner, Tax GTA Industry Leader-Industrial Markets

416-777-3733

Pharmaceuticals
The Pharmaceutical industry is managing a host of issues ranging from underlying factors that drive acquisitions, such as product patent expiry and cost reduction; the integration of pharmaceuticals and healthcare; and establishing a tax efficient supply chain. More specifically, companies in the Pharmaceuticals industry today are dealing with issues that include:

 

  • Sales force compliance
  • Pricing compliance
  • Business model operating structure
  • Operational efficiency
  • Change management
  • Supply chain management
  • Fraud
  • Intellectual property
  • Innovation and research and development
  • Mergers, acquisitions and disposals
  • Market entry and expansion
  • Emerging market companies.

 

At KPMG, our professionals have extensive experience in the Pharmaceutical sector and can help you address these issues. We tailor our services to your industry and your company, and continuously strive to keep abreast of industry trends, drivers and issues through knowledge sharing and industry insights programs.

Our Canadian Pharmaceuticals practice is also part of a global network of KPMG professionals dedicated to assisting businesses of all sizes, from start-ups to large multinational pharmaceutical companies. Through this global network we aim to serve you with the same level of quality and consideration, whether you are operating in fast-growing or emerging markets in the Americas, Asia or Europe.